- Oops!Something went wrong.Please try again later.
ProShares looked set to be the first bitcoin exchange-traded fund, according to sources and fund specialists.
Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.
On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions.
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
The graphics specialist's dominance in this multibillion-dollar market is great news for investors.
After hitting an all-time high of nearly $300 per share earlier this year, shares of CrowdStrike (NASDAQ: CRWD) have slid sharply recently. Trading at about $225 headed into the company's earnings report later this week, the stock is approximately down 25% from its all-time high. Can tech company's upcoming earnings report help revitalize interest in the stock?
Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm.
Shares of Apple (NASDAQ: AAPL) stock closed up 2.2% on Monday following a holiday weekend that featured new commentary on the company and its products from Bloomberg. Last week, if you recall, Apple shares got a boost from reports that the company is planning to build an electric car with autonomous driving capability and also has an augmented reality headset in the works -- one that will be powerful enough to work as a stand-alone device. Well, over the weekend, Bloomberg expanded on these reports, adding that Apple is also working to develop augmented reality (AR) glasses (i.e., something different from the headset) and predicting that consumers (and investors) might get their first look at the AR headset as early as June 2022 if the company decides to unveil it at Apple's planned Worldwide Developers Conference next June.
As I was extolling the virtues of Social Security’s 5.9% COLA, the Centers for Medicare and Medicaid Services (CMS) announced that they were increasing the premium for Medicare Part B by 14.5%. As a reminder, Medicare is composed of two programs. Part A, Hospital Insurance (HI), which covers inpatient hospital services, skilled nursing facilities, home healthcare, and hospice care.
Stock prices can go up and down for a number of reasons in the near term, but over many years, stocks tend to follow the underlying growth of the company. While Alibaba (NYSE: BABA) and Stitch Fix (NASDAQ: SFIX) have seen their share prices crater this year, both companies continue to post solid operating results. Here's why these growth stocks could be bargains at current prices.
A big weekend for advance box office sales and a new product offering were potential good news for believers in AMC's recovery.
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Dow Inc. ( NYSE:DOW...
Uranium stocks are finally in the news after several years, and you don't want to miss this opportunity.
ViacomCBS announced a deal to sell L.A.’s CBS Studio Center to two investment firms for $1.85 billion, the latest in a series of real-estate divestitures for the company. The media conglomerate had confirmed that it was looking to sell CBS Studio Center, which sits on a 55-acre site in Studio City, this summer. The CBS […]
Words have power -- as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
Intel (NASDAQ: INTC) started 2021 with a bang, with shares of the chip giant accelerating in the first quarter of the year thanks to news that it may be gaining ground against rival Advanced Micro Devices (NASDAQ: AMD). Shares of Intel are now trading close to the lower end of their 52-week range. Wall Street doesn't seem to be too optimistic about the company's prospects either, as the stock has an average price target of $54, which points toward a tepid upside from current levels.
Paysafe Limited ( NYSE:PSFE ) is possibly approaching a major achievement in its business, so we would like to shine...
You only have a couple more days to profit in two different ways from tax-loss selling. From a statistical point of view, that means you’re finding a security whose gyrations can explain or predict at least half of the movements of your tax loss sale candidate.
Yahoo Finance Live's Julie Hyman breaks down some of the leading national headlines.
If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer's generic drugs business, Upjohn, and Mylan.